Intellectual Property IP Expert Witness

An IP (Intellectual Property) expert witness is a professional with specialized knowledge in patents, trademarks, copyrights, and trade secrets who provides objective testimony and analysis in legal cases to help judges and juries understand complex IP issues. These experts analyze evidence, interpret technical details, assess infringement, and calculate damages, assisting with patent validity, infringement, and other IP-related disputes to build credible arguments for their clients.

Intellectual Property IP Expert Witness
Michael Arrigo intellectual property IP expert witness. Contact now.
What an IP Expert Witness Does
  • Provides Testimony:

Testifies (often “by report”), or in some cases, in court, deposition, or arbitration to explain technical concepts related to IP to the “trier of fact” (e.g., a jury), helping them understand the evidence and reach factual conclusions. 

  • Analyzes and Interprets Evidence:

    Reviews and analyzes IP-related evidence such as patents, trademarks, copyrights, licensing agreements, and prior art. 

  • Develops Daubert-Standard Opinions:

    Provides expert opinions on issues like patent validity, infringement, validity of copyright, and damages for infringement or misappropriation. 

  • Develops Reports:

    Prepares detailed expert reports that present their findings and opinions in a way that is suitable for legal proceedings and withstands scrutiny. 

  • Assists in Litigation Strategy:

    Helps attorneys understand the technical and legal aspects of their IP cases, strengthens arguments, and provides strategic advice. 

Types of IP Expert Witnesses

IP expert witnesses can specialize in various areas of intellectual property, including: 

  • Patent Experts: With deep expertise in specific technologies, patent law, analyzing patent claims, and evaluating prior art. 
  • Trademark Experts: Focus on trademark disputes and the infringement of trademarks. 
  • Copyright Experts: Provide testimony on issues related to copyright law and infringement. 
  • Trade Secret Experts: Specialize in cases of trade secret misappropriation. 
  • IP Damages Experts: Focus on the economic analysis of intellectual property damages, including lost profits and reasonable royalties. 
Why They Are Important
  • Clarifies Complex Subject Matter:

    In complex cases involving intricate technologies or legal nuances, expert witnesses are crucial for making complicated information understandable to non-experts. 

  • Supports Credibility:

    Objective testimony from a highly qualified expert can significantly strengthen a party’s arguments and build credibility with the court. 

  • Meets Legal Standards:

    Experts are required to meet stringent admissibility standards, ensuring their testimony is reliable and can be used in court. 

Michael Arrigo specific expertise in intellectual property and electronic health record patents

INTELLECTUAL PROPERTY – ELECTRONIC HEALTH RECORDS EXEMPLAR CASE

Retained as an expert witness regarding Motions for Summary Judgment of Invalidity Under 35 U.S.C. § 101. I base the opinions provided herein on my review of the’040 patent and the ’048 patent, including the specifications and the claims, the prosecution history of the’040 patent and the ’048 patent, my review of certain documents in this case and related cases, my discussions with outside counsel, and my experience.

  1. I was requested to review:

U.S. Pat. No. 7,464,040 (“the ’040 patent”)

U.S. Pat. No. 7,490,048 (“the ’048 patent”)

Pleadings and exhibits

  1. I was requested to provide opinions on whether the ‘040 patent and the ‘048 patent:
  1. identify novel concepts compared to the generally accepted methods of managing and sharing patient data and sending medical insurance claims that were available in 1999 in the healthcare industry
  2. identify novel processes, methods, and apparatus to address known problems in the healthcare industry, including those contested in Defendants’ Motion for Summary Judgement of Invalidity Under 35 U.S.C. § 101
    1. “…problems associated with “inaccurate and/or erroneous information” in the healthcare context,[i]
    2. “patient information [that is] not . . . uniformly distributed and/or . . . available to providers at the point of treatment,” [ii]
    3. “[f]raudulent claims and/or claims which cannot be verified,” [iii]
  1. Address these problems in the healthcare industry via a novel method, e.g., “a comprehensive healthcare processing system which can manage patient and client records, doctor and other provider records, healthcare insurance and/or payer records, and thereby provide an apparatus, system, and methods for providing a variety and a multitude of healthcare information processing applications, processes, and services.” [iv]

[i] Defendants Motion for Summary Judgement of Invalidity Under 35 U.S.C. § 101, page 2

[ii] Id.

[iii] Id.

[iv] Id.,

Expert admission regarding electronic health records

In UNITED STATES OF AMERICA ex rel. Alex Permenter, Chris Wheeler, and Eric Rodighiero, Plaintiffs/Relators v. eClinicalWorks, LLC. UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF GEORGIA, MACON DIVISION. Case No. 5:18-CV-382, a Qui Tam False Claims Act case.   On June 4, 2025 U.S. District Judge Marc T. Treadwell DENIED Defendant’s motion to exclude the opinions of Relator’s Expert Michael Arrigo. Expert scope: Electronic Health Record certification standards, with focus on the privacy and security E.H.R. Certification Standards as set forth in 42 CFR 315 – ONC certification criteria:

  • 170.315 (d)(1) Authentication, access control, authorization
  • 170.315 (d)(2) Auditable Events and Tamper-Resistance
  • 170.315 (d)(3) Audit Reports
  • 170.315 (d)(4) Amendments
  • 170.315 (d)(5) Automatic Access Timeout
  • 170.315 (d)(6) Emergency Access
  • 170.315 (d)(7) End-user Device Encryption
  • 170.315 (d)(8) Integrity
  • 170.315 (d)(9)(ii) Trusted Connection when transporting ePHI
  • 170.315 (d)(11) Accounting of Disclosures
  • 170.315 (d)(12) Encrypt Authentication Credentials

Michael F. Arrigo

Michael Arrigo, an expert witness, and healthcare executive, brings four decades of experience in the software, financial services, and healthcare industries. In 2000, Mr. Arrigo founded No World Borders, a healthcare data, regulations, and economics firm with clients in the pharmaceutical, medical device, hospital, surgical center, physician group, diagnostic imaging, genetic testing, health I.T., and health insurance markets. His expertise spans the federal health programs Medicare and Medicaid and private insurance. He advises Medicare Advantage Organizations that provide health insurance under Part C of the Medicare Act. Mr. Arrigo serves as an expert witness regarding medical coding and billing, fraud damages, and electronic health record software for the U.S. Department of Justice. He has valued well over $1 billion in medical billings in personal injury liens, malpractice, and insurance fraud cases. The U.S. Court of Appeals considered Mr. Arrigo's opinion regarding loss amounts, vacating, and remanding sentencing in a fraud case. Mr. Arrigo provides expertise in the Medicare Secondary Payer Act, Medicare LCDs, anti-trust litigation, medical intellectual property and trade secrets, HIPAA privacy, health care electronic claim data Standards, physician compensation, Anti-Kickback Statute, Stark law, the Affordable Care Act, False Claims Act, and the ARRA HITECH Act. Arrigo advises investors on merger and acquisition (M&A) diligence in the healthcare industry on transactions cumulatively valued at over $1 billion. Mr. Arrigo spent over ten years in Silicon Valley software firms in roles from Product Manager to CEO. He was product manager for a leading-edge database technology joint venture that became commercialized as Microsoft SQL Server, Vice President of Marketing for a software company when it grew from under $2 million in revenue to a $50 million acquisition by a company now merged into Cincom Systems, hired by private equity investors to serve as Vice President of Marketing for a secure email software company until its acquisition and multi $million investor exit by a company now merged into Axway Software S.A. (Euronext: AXW.PA), and CEO of one of the first cloud-based billing software companies, licensing its technology to Citrix Systems (NASDAQ: CTXS). Later, before entering the healthcare industry, he joined Fortune 500 company Fidelity National Financial (NYSE: FNF) as a Vice President, overseeing eCommerce solutions for the mortgage banking industry. While serving as a Vice President at Fortune 500 company First American Financial (NYSE: FAF), he oversaw eCommerce and regulatory compliance technology initiatives for the top ten mortgage banks and led the Sarbanes Oxley Act Section 302 internal controls I.T. audit for the company, supporting Section 404 of the Sarbanes Oxley Act. Mr. Arrigo earned his Bachelor of Science in Business Administration from the University of Southern California. Before that, he studied computer science, statistics, and economics at the University of California, Irvine. His post-graduate studies include biomedical ethics at Harvard Medical School, biomedical informatics at Stanford Medical School, blockchain and crypto-economics at the Massachusetts Institute of Technology, and training as a Certified Professional Medical Auditor (CPMA). Mr. Arrigo is qualified to serve as a director due to his experience in healthcare data, regulations, and economics, his leadership roles in software and financial services public companies, and his healthcare M&A diligence and public company regulatory experience. Mr. Arrigo is quoted in The Wall Street Journal, Fortune Magazine, Kaiser Health News, Consumer Affairs, National Public Radio (NPR), NBC News Houston, USA Today / Milwaukee Journal Sentinel, Medical Economics, Capitol ForumThe Daily Beast, the Lund Report, Inside Higher Ed, New England Psychologist, and other press and media outlets. He authored a peer-reviewed article regarding clinical documentation quality to support accurate medical coding, billing, and good patient care, published by Healthcare Financial Management Association (HFMA) and published in Healthcare I.T. News. Mr. Arrigo serves as a member of the board of directors of a publicly traded company in the healthcare and data analytics industry, where his duties include: member, audit committee; chair, compensation committee; member, special committee.

Leave a Reply